United States & Hong Kong Biotech Company Insilico Medicine Plans Hong Kong IPO after Raising $110 Million in Series E Funding at $1 Billion Valuation, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec
5th June | Hong Kong
United States & Hong Kong biotech company Insilico Medicine is planning a Hong Kong IPO after raising $110 million in Series E funding at $1 billion valuation. Insilico Medicine was founded in 2014 by Alex Zhavoronkov & Alex Aliper. Insilico Medicine investors include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec. Profile – Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.
“ United States & Hong Kong Biotech Company Insilico Medicine Plans Hong Kong IPO after Raising $110 Million in Series E Funding at $1 Billion Valuation, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec “
United States & Hong Kong Biotech Company Insilico Medicine Plans Hong Kong IPO after Raising $110 Million in Series E Funding at $1 Billion Valuation, Founded in 2014 by Alex Zhavoronkov & Alex Aliper, Investors Include Value Partners, Warburg Pincus, B Capital Group, Eli Lilly & Co Venture Unit, Qiming Venture Partners & Wuxi AppTec

Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit